Skip to main content
. Author manuscript; available in PMC: 2021 Jun 28.
Published in final edited form as: IEEE Int Ultrason Symp. 2020 Nov 17;2020:10.1109/ius46767.2020.9251660. doi: 10.1109/ius46767.2020.9251660

Figure 4:

Figure 4:

HCC tumor response to low, high and sham AVUS therapies. Opposite response are observed in low and high dose AVUS therapies.